{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:03:35Z","timestamp":1779944615201,"version":"3.53.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD102337-01A1"],"award-info":[{"award-number":["R01HD102337-01A1"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["archives-pmr.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.apmr.2025.08.005","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:20:25Z","timestamp":1755620425000},"page":"443-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal Association Between Reported Use of Psychoactive Substances and Cognitive Function in Individuals With Multiple Sclerosis"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-4463","authenticated-orcid":false,"given":"Jeeyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Ehde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Alschuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora E.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apmr.2025.08.005_bib0001","unstructured":"National Institute of Neurological Disorders and Stroke. Multiple sclerosis. Available at: https:\/\/www.ninds.nih.gov\/health-information\/disorders\/multiple-sclerosis. Accessed May 1, 2025."},{"key":"10.1016\/j.apmr.2025.08.005_bib0002","unstructured":"National Multiple Sclerosis Society. Who gets MS? National Multiple Sclerosis Society. Available at: https:\/\/www.nationalmssociety.org\/understanding-ms\/what-is-ms\/who-gets-ms. Accessed March 1, 2025."},{"key":"10.1016\/j.apmr.2025.08.005_bib0003","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1352458506071346","article-title":"The scope and nature of pain in persons with multiple sclerosis","volume":"12","author":"Ehde","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.apmr.2025.08.005_bib0004","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1586\/ern.10.99","article-title":"Multiple sclerosis-associated fatigue","volume":"10","author":"Krupp","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.apmr.2025.08.005_bib0005","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s00415-009-5257-5","article-title":"Symptomatology of MS: results from the German MS registry","volume":"256","author":"Stuke","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.apmr.2025.08.005_bib0006","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in Multiple Sclerosis: a systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.apmr.2025.08.005_bib0007","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.0b013e318212a8be","article-title":"MRI predictors of cognitive outcome in early multiple sclerosis","volume":"76","author":"Deloire","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2025.08.005_bib0008","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11910-020-01045-3","article-title":"Cognitive dysfunction in the early stages of multiple sclerosis-how much and how important?","volume":"20","author":"Oset","year":"2020","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.apmr.2025.08.005_bib0009","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1212\/WNL.0000000000002564","article-title":"Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity","volume":"86","author":"Berrigan","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2025.08.005_bib0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41398-023-02555-7","article-title":"Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis","volume":"13","author":"Margoni","year":"2023","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.apmr.2025.08.005_bib0011","article-title":"Cannabinoid use among Americans with MS: current trends and gaps in knowledge","volume":"6","author":"Braley","year":"2020","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.apmr.2025.08.005_bib0012","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1352458506070947","article-title":"Cannabis use in patients with multiple sclerosis","volume":"12","author":"Chong","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.apmr.2025.08.005_bib0013","first-page":"682","article-title":"The efficacy of cannabis on multiple sclerosis-related symptoms","volume":"12","author":"Haddad","year":"2022","journal-title":"Life (Basel)"},{"key":"10.1016\/j.apmr.2025.08.005_bib0014","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.apmr.2023.04.012","article-title":"Risk factors for chronic prescription opioid use in multiple sclerosis","volume":"104","author":"Turner","year":"2023","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.08.005_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brat.2016.06.005","article-title":"The effects of alcohol on emotion in social drinkers","volume":"88","author":"Sayette","year":"2017","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.apmr.2025.08.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297235","article-title":"Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: preliminary evidence from a single-arm pilot clinical trial","volume":"19","author":"Dadvar","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.apmr.2025.08.005_bib0017","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jns.2013.12.029","article-title":"Alcohol and substance use in multiple sclerosis","volume":"338","author":"Beier","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.apmr.2025.08.005_bib0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1191\/1352458504ms989oa","article-title":"Alcohol and drug abuse among persons with multiple sclerosis","volume":"10","author":"Bombardier","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.apmr.2025.08.005_bib0019","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00415-017-8715-5","article-title":"Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis","volume":"265","author":"Brenton","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.apmr.2025.08.005_bib0020","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.0b013e318212ab0c","article-title":"Effects of cannabis on cognitive function in patients with multiple sclerosis","volume":"76","author":"Honarmand","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2025.08.005_bib0021","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/acps.13539","article-title":"Functional and structural brain abnormalities in substance use disorder: a multimodal meta-analysis of neuroimaging studies","volume":"147","author":"Yan","year":"2023","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.apmr.2025.08.005_bib0022","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/01.wnl.0000304046.23960.25","article-title":"Multiple sclerosis and cannabis: a cognitive and psychiatric study","volume":"71","author":"Ghaffar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2025.08.005_bib0023","article-title":"Cannabis and cognitive functioning in multiple sclerosis: the role of gender","volume":"3","author":"Patel","year":"2017","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.apmr.2025.08.005_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X241293114","article-title":"The effects of coffee\/caffeine in patients with multiple sclerosis; a systematic review","volume":"29","author":"Salekzamani","year":"2024","journal-title":"J Evid Based Integr Med"},{"key":"10.1016\/j.apmr.2025.08.005_bib0025","doi-asserted-by":"crossref","DOI":"10.2196\/59876","article-title":"Optimizing detection and prediction of cognitive function in multiple sclerosis with ambulatory cognitive tests: protocol for the longitudinal observational CogDetect-MS study","volume":"13","author":"Kratz","year":"2024","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.apmr.2025.08.005_bib0026","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2377-13-37","article-title":"Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis","volume":"13","author":"Learmonth","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.apmr.2025.08.005_bib0027","unstructured":"J. Mogle, N. Hill and M. Sliwinski, Assessing daily subjective cognition: distinguishing memory and attention problems from overall cognitive functioning, In: Paper presented at: Society for Ambulatory Assessment Conference, Syracuse, NY, June 19\u201322, 2019."},{"key":"10.1016\/j.apmr.2025.08.005_bib0028","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1073191116643164","article-title":"Reliability and validity of ambulatory cognitive assessments","volume":"25","author":"Sliwinski","year":"2018","journal-title":"Assessment"},{"key":"10.1016\/j.apmr.2025.08.005_bib0029","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/13524585251320814","article-title":"Feasibility, reliability, and validity of ambulatory smartphone-administered cognitive tests in multiple sclerosis","volume":"31","author":"Goga","year":"2025","journal-title":"Mult Scler"},{"key":"10.1016\/j.apmr.2025.08.005_bib0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archpsyc.61.3.310","article-title":"Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the archives of general psychiatry","volume":"61","author":"Gueorguieva","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.apmr.2025.08.005_bib0031","unstructured":"Kreidler SM. GLIMMPSE software 3.0: free sample size tools for multilevel and longitudinal data. Available at: https:\/\/glimmpse.samplesizeshop.org\/. Accessed July 14, 2025."},{"key":"10.1016\/j.apmr.2025.08.005_bib0032","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/j.1530-0277.2010.01277.x","article-title":"Study of metamemory in patients with chronic alcoholism using a feeling-of-knowing episodic memory task","volume":"34","author":"Le Berre","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.apmr.2025.08.005_bib0033","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1097\/PR9.0000000000000669","article-title":"Effects of long-term opioid analgesics on cognitive performance and plasma cytokine concentrations in patients with chronic low back pain: a cross-sectional pilot study","volume":"3","author":"Richards","year":"2018","journal-title":"Pain Rep"},{"key":"10.1016\/j.apmr.2025.08.005_bib0034","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/jcr.2016.0005","article-title":"Moderate caffeine intake and verbal memory in multiple sclerosis: a pilot study","volume":"6","author":"Segal\u00e0","year":"2016","journal-title":"J Caffeine Res"},{"key":"10.1016\/j.apmr.2025.08.005_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0376-8716(98)00077-5","article-title":"Caffeine\u2014an atypical drug of dependence","volume":"51","author":"Daly","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.apmr.2025.08.005_bib0036","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.3233\/JAD-2010-091315","article-title":"Is caffeine a cognitive enhancer?","volume":"20","author":"Nehlig","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.apmr.2025.08.005_bib0037","first-page":"89","article-title":"Alcohol-related cognitive impairments: an overview of how alcoholism may affect the workings of the brain","volume":"19","author":"Evert","year":"1995","journal-title":"Alcohol Health Res World"},{"key":"10.1016\/j.apmr.2025.08.005_bib0038","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/WNL.0000000000000063","article-title":"Alcohol consumption and cognitive decline in early old age","volume":"82","author":"Sabia","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2025.08.005_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2023.1007477","article-title":"The impact of post-encoding alcohol consumption on episodic memory recall and remember-know responses in heavy drinkers","volume":"14","author":"Butterworth","year":"2023","journal-title":"Front Psychol"},{"key":"10.1016\/j.apmr.2025.08.005_bib0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/alcalc\/agn118","article-title":"The Korsakoff syndrome: clinical aspects, psychology and treatment","volume":"44","author":"Kopelman","year":"2009","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.apmr.2025.08.005_bib0041","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/ijerph7041540","article-title":"Ethanol and cognition: indirect effects, neurotoxicity and neuroprotection: a review","volume":"7","author":"Brust","year":"2010","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.apmr.2025.08.005_bib0042","series-title":"Effects of alcohol abuse on the brain. Handbook of the medical consequences of alcohol and drug abuse","author":"Crews","year":"2004"},{"key":"10.1016\/j.apmr.2025.08.005_bib0043","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1369-1600.2011.00418.x","article-title":"Widespread and sustained cognitive deficits in alcoholism: a meta-analysis","volume":"18","author":"Stavro","year":"2013","journal-title":"Addict Biol"},{"key":"10.1016\/j.apmr.2025.08.005_bib0044","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/apmr.2003.50107","article-title":"A typology of alcohol use patterns among persons with recent traumatic brain injury or spinal cord injury: implications for treatment matching","volume":"84","author":"Turner","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.08.005_bib0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apmr.2025.08.005_bib0046","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/cells13131130","article-title":"Effects of cannabis on glutamatergic neurotransmission: the interplay between cannabinoids and glutamate","volume":"13","author":"Chowdhury","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.apmr.2025.08.005_bib0047","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis","volume":"33","author":"D'Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.apmr.2025.08.005_bib0048","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0269881108092393","article-title":"Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users","volume":"23","author":"Ramaekers","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.apmr.2025.08.005_bib0049","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]","volume":"197","author":"Morgan","year":"2010","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.apmr.2025.08.005_bib0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hup.1196","article-title":"A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use","volume":"26","author":"Schoedel","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.apmr.2025.08.005_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104173","article-title":"Effects of Sativex\u00ae on cognitive function in patients with multiple sclerosis: a systematic review and meta-analysis","volume":"68","author":"Dykukha","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.apmr.2025.08.005_bib0052","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-010-1848-1","article-title":"Meta-analysis of the acute effects of nicotine and smoking on human performance","volume":"210","author":"Heishman","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.apmr.2025.08.005_bib0053","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bcp.2013.04.001","article-title":"Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex","volume":"85","author":"Wallace","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apmr.2025.08.005_bib0054","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinternmed.2010.393","article-title":"Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia","volume":"171","author":"Rusanen","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.apmr.2025.08.005_bib0055","first-page":"9","article-title":"Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids","volume":"17","author":"Schiltenwolf","year":"2014","journal-title":"Pain Physician"},{"key":"10.1016\/j.apmr.2025.08.005_bib0056","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12966-023-01536-9","article-title":"Physical activity and cognitive function: moment-to-moment and day-to-day associations","volume":"20","author":"Kekalainen","year":"2023","journal-title":"Int J Behav Nutr Phys Act"}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999325008548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999325008548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:23:36Z","timestamp":1779942216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999325008548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0003999325008548"],"URL":"https:\/\/doi.org\/10.1016\/j.apmr.2025.08.005","relation":{},"ISSN":["0003-9993"],"issn-type":[{"value":"0003-9993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal Association Between Reported Use of Psychoactive Substances and Cognitive Function in Individuals With Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Archives of Physical Medicine and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmr.2025.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Congress of Rehabilitation Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}